Average Co-Inventor Count = 2.19
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Hoffmann-la Roche Inc. (77 from 4,945 patents)
2. Siena Biotech S.p.a. (5 from 11 patents)
3. Basilea Pharmaceutica Ag (4 from 68 patents)
4. Other (2 from 832,843 patents)
5. Degussa Aktiengesellschaft (2 from 1,678 patents)
6. F. Hoffmann-la Roche Ag (2 from 168 patents)
7. Roche Vitamins Inc. (1 from 173 patents)
8. Degussa - Huls Ag (1 from 145 patents)
9. Hoppman-la Rouche Ag (1 from 1 patent)
87 patents:
1. 12012466 - Peptide macrocycles against
2. 11447478 - BACE1 inhibitors
3. 11098080 - Peptide macrocycles against Acinetobacter baumannii
4. 11066443 - Anti-bacterial peptide macrocycles and use thereof
5. 10457667 - Indolin-2-one derivatives
6. 10385050 - Indolin-2-one and 1,3-dihydro-pyrrolo[3,2-c]pyridin-2-one derivatives
7. 10377746 - Indolin-2-one derivatives
8. 10112938 - Indolin-2-one and 1,3-dihydro-pyrrolo[3,2-c]pyridin-2-one derivatives
9. 10030047 - Peptide macrocycles against acinetobacter baumannii
10. 9988390 - Pyrimidone derivatives and their use in the treatment, amelioration or prevention of a viral disease
11. 9616053 - Indolin-2-one or pyrrolo-pyridin/pyrimidin-2-one derivatives
12. 9273042 - 5-amino[1,4]thiazines as BACE 1 inhibitors
13. 9242943 - 1,4 oxazines as BACE1 and/or BACE2 inhibitors
14. 9181232 - Difluoro-hexahydro-cyclopentaoxazinyls and difluoro-hexahydro-benzooxazinyls as BACE1 inhibitors
15. 9115098 - 1,3-oxazines as BACE1 and/or BACE2 inhibitors